Mary R Lee

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. doi request reprint Gender differences in neural-behavioral response to self-observation during a novel fMRI social stress task
    Mary R Lee
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, United States Electronic address
    Neuropsychologia 53:257-63. 2014
  2. pmc A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback
    M R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse NIDA, Intramural Research Program, Baltimore, 21224, USA
    Genes Brain Behav 12:554-63. 2013
  3. ncbi request reprint Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study
    Mary R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA
    Schizophr Res 145:110-5. 2013
  4. pmc Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans
    Mary R Lee
    National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland, United States of America
    PLoS ONE 6:e24203. 2011
  5. doi request reprint Prefrontal white matter impairment in substance users depends upon the catechol-o-methyl transferase (COMT) val158met polymorphism
    Xiaochu Zhang
    Neuroimaging Research Branch, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Neuroimage 69:62-9. 2013
  6. pmc Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat
    Thomas C Jhou
    Behavioral Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA
    Psychopharmacology (Berl) 224:303-12. 2012
  7. doi request reprint Addiction and corticotropin-releasing hormone type 1 receptor antagonist medications
    Carlo Contoreggi
    Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Ann N Y Acad Sci 1282:107-18. 2013

Collaborators

Detail Information

Publications7

  1. doi request reprint Gender differences in neural-behavioral response to self-observation during a novel fMRI social stress task
    Mary R Lee
    Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, United States Electronic address
    Neuropsychologia 53:257-63. 2014
    ..During fMRI scanning, subjects were shown alternating video clips of two..
  2. pmc A preliminary study suggests that nicotine and prefrontal dopamine affect cortico-striatal areas in smokers with performance feedback
    M R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse NIDA, Intramural Research Program, Baltimore, 21224, USA
    Genes Brain Behav 12:554-63. 2013
    ....
  3. ncbi request reprint Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study
    Mary R Lee
    Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 21224, USA
    Schizophr Res 145:110-5. 2013
    ....
  4. pmc Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans
    Mary R Lee
    National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland, United States of America
    PLoS ONE 6:e24203. 2011
    ....
  5. doi request reprint Prefrontal white matter impairment in substance users depends upon the catechol-o-methyl transferase (COMT) val158met polymorphism
    Xiaochu Zhang
    Neuroimaging Research Branch, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA
    Neuroimage 69:62-9. 2013
    ....
  6. pmc Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat
    Thomas C Jhou
    Behavioral Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD, USA
    Psychopharmacology (Berl) 224:303-12. 2012
    ....
  7. doi request reprint Addiction and corticotropin-releasing hormone type 1 receptor antagonist medications
    Carlo Contoreggi
    Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA
    Ann N Y Acad Sci 1282:107-18. 2013
    ..Investigators designing future trials might refocus their understanding of addiction and treatment in this new direction...